Plasma levels of tissue inhibitor of matrix metalloproteinase-1 correlate with diagnosis and prognosis of glioma patients.

MLA

Lin, Yi, et al. “Plasma Levels of Tissue Inhibitor of Matrix Metalloproteinase-1 Correlate with Diagnosis and Prognosis of Glioma Patients.” Chinese Medical Journal, vol. 126, no. 22, Nov. 2013, pp. 4295–300. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=24238516&authtype=sso&custid=ns315887.

APA

Lin, Y., Wang, J.-F., Gao, G.-Z., Zhang, G.-Z., Wang, F.-L., & Wang, Y.-J. (2013). Plasma levels of tissue inhibitor of matrix metalloproteinase-1 correlate with diagnosis and prognosis of glioma patients. Chinese Medical Journal, 126(22), 4295–4300.

Chicago

Lin, Yi, Jiang-Fei Wang, Guang-Zu Gao, Guo-Zhen Zhang, Fei-Long Wang, and Yun-Jie Wang. 2013. “Plasma Levels of Tissue Inhibitor of Matrix Metalloproteinase-1 Correlate with Diagnosis and Prognosis of Glioma Patients.” Chinese Medical Journal 126 (22): 4295–4300. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=24238516&authtype=sso&custid=ns315887.